CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing Post author: Post published:December 4, 2023 Post category:uncategorized CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH). You Might Also Like Novel immunization strategies can markedly increase mucosal immunity in nonhuman primates December 16, 2023 Cardiovascular disease risk linked to early brain decline in men November 26, 2024 New guidelines proposed to reduce unnecessary medical interventions for breath-holding spells in children November 23, 2023
Novel immunization strategies can markedly increase mucosal immunity in nonhuman primates December 16, 2023
New guidelines proposed to reduce unnecessary medical interventions for breath-holding spells in children November 23, 2023